Sage Therapeutics Looks to File NDA for Postpartum Depression Treatment Later This Year
During the J.P. Morgan Healthcare Conference, Sage provided an update on its long-term strategy to drive growth at the company. Source: BioSpace
During the J.P. Morgan Healthcare Conference, Sage provided an update on its long-term strategy to drive growth at the company. Source: BioSpace
Y Combinator is launching an accelerator fund for early-stage life science companies in the lab phase focused on longevity and aging. Source: BioSpace
Based in Santa Clara, California, CBT Pharma was spun out of Crown Bioscience with four development-stage assets in the oncology space. Source: BioSpace
The EU approval is based on data from three pivotal Phase III studies from the ORCHESTRA trial programme of 2,388 patients who met primary and nearly all key secondary endpoints.…
A look at 6 up and coming blood-testing startups. Source: BioSpace
A federal judge has temporarily blocked the Trump administration's efforts to wind down DACA. Source: BioSpace
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer. Source: BioSpace
The company believes the Translarna data is compelling and pointed to the success the drug is having in Europe. Source: BioSpace
Here's a look at the seven best life science companies to work for in 2018. Source: BioSpace
Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage. Source: BioSpace